One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...
A new paper in Science Advances details how scientists have succeeded in mapping a central part of the immune system—the HLA class II molecules—while accurately predicting how they display fragments ...
AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking ...
Using genetically engineered mice expressing a specific variant of HLA, researchers uncover the instrumental role of this protein in the development of drug eruptions. They found that when HLA binds ...
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results